Prostate-specific TAAs such as Prostate-Specific Antigen (PSA) and Prostatic Acid Phosphatase (PAP) may be loaded onto DCs encoded in mRNA to boost anti-tumor cell immune recognition (118). Here, KLK3 is linked to neoplasm.